Project

Rivercyte

rivercyte

Technology for Rapid Physical Phenotyping of Cells

Scientists from the Division Prof. Guck from the MPI for the Physics of Light founded the company Rivercyte together with the director in May 2022. There, the team combines years of experience in the fields of deformability cytometry, deep learning, hardware and software development to establish a novel technology for rapid physical phenotyping of cells. The core technology is based on a microfluidic chip through which cells flow and deform. An image of each cell is captured using high-speed microscopy and analyzed with AI-based software. With the developed technology, Rivercyte offers an invaluable tool for detecting abnormalities in cell samples and automating routine analysis procedures in life sciences and medicine.

phaseFoundet
Area:Life Science / MedTech
Goal/ Vision:

The goal is to develop low-cost device and AI based software for rapid and automated analysis of single cells.

Institute:

Max Planck Institute of the Science of Light, Erlangen

Contact:Max Planck Institut für die Physik des Lichts

Staudtstraße 2
D-91058 Erlangen



Rivercyte GmbH
Henkestr. 91
91052 Erlangen

Hello@rivercyte.com

Website:http://www.rivercyte.com